The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...

Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.

TORONTO — Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this ...

A third dose of the Pfizer COVID-19 vaccine can "strongly" boost protection against the delta variant, suggests new data released by Pfizer.

Pfizer’s clinical trials in children 5 to 11 did not measure the vaccine’s effectiveness against COVID-19. Effectiveness was “never the intended primary endpoint,” Anderson said.

Pfizer also said it is working to improve its existing vaccine formulation, developed jointly with Germany's BioNTech, based on the vaccine's reaction to new COVID-19 variants that arise.

London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already.

A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri, U.S. in an undated photograph.